Valeant Pharmaceuticals International, Inc.·4

Apr 28, 9:57 PM ET

Masterson Richard Kevin 4

4 · Valeant Pharmaceuticals International, Inc. · Filed Apr 28, 2011

Insider Transaction Report

Form 4
Period: 2011-04-26
Masterson Richard Kevin
Pres.&COO, Valeant Int.(BB)SRL
Transactions
  • Tax Payment

    Common Shares, no par value

    2011-04-26$52.19/sh2,124$110,85234,707 total
Footnotes (2)
  • [F1]Common shares withheld from the issuance of common shares to the Reporting Person to satisfy the tax withholding obligations due upon vesting of performance based restricted share units (PSUs).
  • [F2]This number represents common shares received upon vesting of PSUs, as well as PSUs that were previously reported in Table I of an amended Form 3 filed on April 13, 2011.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT